Influence of Pancreatic Transection With CUSA on Postoperative Pancreatic Fistula Incidence (PANCUT)
Study Details
Study Description
Brief Summary
Objective: To compare the outcomes after elective pancreatic resections using cavitron ultrasonic surgical aspirator (CUSA) and selective closure of small blood vessels and branch pancreatic ducts versus surgical scalpel or stapler for the transection of pancreatic tissue.
Study design: A randomized controlled, single centre trial.
Study population: Two groups of 80 patients (160 in total) scheduled for elective open pancreaticoduodenectomy (PD) for any indication.
Intervention: Transection of pancreatic tissue with CUSA.
Control: Standard transection of pancreatic tissue with surgical scalpel (in PD) or stapler (in DP)
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
Rationale: Postoperative pancreatic fistula (POPF) is one of the major causes of morbidity and mortality after pancreatic resections. There is no predominant surgical technique of pancreatic stump closure in distal pancreatectomy (DP) or formation of pancreaticojejunostomy in pancreaticoduodenectomy (PD) proven to prevent/lower POPF incidence. Cavitron ultrasonic surgical aspirator (CUSA) selectively removes tissue parenchyma, evading blood vessels and pancreatic ducts which could consequently be selectively ligated. Such technique could anull pancreatic juice drainage from branch ducts and provide better (skeletonised) view of the main duct to from an anastomosis (or to ligate it in DP) and thus lower the incidence of POPF formation.
Objective: To compare transection of pancreatic tissue with CUSA and selective closure of small blood vessels and branch pancreatic ducts with transection with surgical scalpel or stapler in elective pancreatic resections regarding the incidence of POPF.
Study design: A randomized controlled, single centre trial. The study protocol was designed according to the SPIRIT guidelines.
Study population: Two groups of 80 patients (160 in total) scheduled for elective open pancreaticoduodenectomy (PD) for any indication.
Intervention: Transection of pancreatic tissue with CUSA.
Control: Standard transection of pancreatic tissue with surgical scalpel (in PD).
Main study parameters/endpoints: Primary outcome is the incidence of POPF. Main secondary outcomes are intraoperative outcomes (such as blood loss and operative time), postoperative outcomes (such as complications, time to functional recovery and hospital stay).
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Experimental: Transection with CUSA Transection of pancreatic tissue using cavitron ultrasonic surgical aspirator (CUSA) and using metal clips for closing small intraparenchymal blood vessels and pancreatic branch ducts. |
Device: Cavitron ultrasonic surgical aspirator (CUSA)
Transection of pancreatic tissue with cavitron ultrasonic surgical aspirator (CUSA).
|
| Sham Comparator: Transection with scalpel/stapler Standard transection of pancreatic tissue with a surgical scalpel without selective closure of small blood vessels and branch pancreatic ducts (in pancreaticoduodenectomy). |
Other: Scalpel
Transection of pancreatic tissue with scalpel.
|
Outcome Measures
Primary Outcome Measures
- Postoperative pancreatic fistula incidence [30 days]
Evaluation and incidence of postoperative pancreatic fistula
Secondary Outcome Measures
- Postoperative septic complications [90 days]
Intraabdominal collections, antibiotic treatment
- Number of postoperative interventions [90 days]
Percutaneous drain placement or reoperations
- Hospital stay [90 days]
Days in hospital
- Volume of intraoperative blood loss [1 day]
Blood loss during surgery
- Operative time [1 day]
Time spent for pancreas transection
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients aged 18 years or more
-
Patients capable of understanding the provided information about the study
-
Patients with signed informed consent
-
Planned elective pancreaticoduodenectomy for any indication
Exclusion Criteria:
-
Patients aged less than 18
-
Patient incapable of understanding the provided information about the study
-
Pregnancy
-
Previous surgical procedures on pancreas
-
Immunosuppressive therapy
-
Preoperative radiotherapy
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University Medical Centre Ljubljana | Ljubljana | Slovenia | 1000 |
Sponsors and Collaborators
- University Medical Centre Ljubljana
Investigators
- Principal Investigator: David Badovinac, Department of Abdominal Surgery, University Medical Centre Ljubljana
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 20230052